文献速递主动脉疾病

EVAR支架尺寸选择与内漏、再干预及死亡率的关系:GREAT注册分析

Aortic endograft sizing and endoleak, reintervention, and mortality following endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2021-05-01

基于GREAT注册中3607例EVAR患者,分析支架尺寸与IFU的符合情况及性别影响。仅53%尺寸在IFU范围内,女性更易近端支架偏小和髂支偏大。近端支架偏小与内漏及主动脉/全因死亡相关,髂支偏小与内漏及再干预相关,偏大无不良结局关联。

要点

  • 仅53%的EVAR支架尺寸在IFU范围内,22%偏大、15%偏小、10%混合偏大偏小。
  • 女性更易近端支架偏小和髂支偏大,男性更易髂支偏小。
  • 近端支架偏小与内漏及主动脉/全因死亡相关,髂支偏小与内漏及再干预相关。

核心结论

  • 近端支架偏小与内漏及主动脉和全因死亡相关,髂支偏小与内漏及器械相关再干预相关。
  • 支架偏大未与不良结局相关,女性更易近端偏小和髂支偏大而男性更易髂支偏小。

研究设计与样本

  • 基于W.L. Gore & Associates全球主动脉治疗注册(GREAT)中截至2020年3月全部接受EVAR的3607例患者进行回顾性分析。

主要发现

  • 1896例(53%)尺寸在IFU内,791例(22%)偏大,540例(15%)偏小,380例(10%)同时存在偏大和偏小。
  • 预测超出IFU尺寸的因素包括女性(P = .001)、非白人种族(P = .0003)、近端瘤颈长度较短(P < .061)或髂动脉直径较大(P < .0001)。
  • 近端支架偏小与内漏(HR 1.8)、主动脉死亡(HR 60.5)和全因死亡(HR 18.0)相关。
  • 髂支偏小与内漏(HR 1.5)和器械相关再干预(HR 1.4)相关,髂支超出IFU尺寸与主动脉死亡(HR 2.6)和全因死亡(HR 1.3)相关。
  • 近端和远端支架偏大均未与不良结局相关。

关键数值与推荐

  • 近端支架偏小与内漏风险比1.8、主动脉死亡风险比60.5、全因死亡风险比18.0相关。
  • 髂支偏小与内漏风险比1.5、器械相关再干预风险比1.4相关。
  • 髂支超出IFU尺寸与主动脉死亡风险比2.6、全因死亡风险比1.3相关。

临床怎么用

  • EVAR术前应严格按IFU选择支架尺寸,尤其关注近端瘤颈和髂支的尺寸匹配。
  • 对女性、非白人、近端瘤颈短或髂动脉直径大的患者,应警惕尺寸超出IFU的风险。
  • 避免近端支架偏小和髂支偏小,以降低内漏、再干预和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endograft sizing for endovascular abdominal aortic aneurysm repair (EVAR) is not consistent despite published instructions for use (IFU). We sought to identify factors associated with over/undersizing, determine sex influence on sizing, and examine sizing effects on endoleak, reintervention, and mortality by analyzing data obtained from the W.L. Gore & Associates Global Registry for Endovascular Aortic Treatment (GREAT). METHODS: All patients enrolled in GREAT undergoing EVAR were included for analysis. Proximal/distal aortic landing zones were compared with device implanted to assess sizing as related to IFU. χ2/Fisher exact tests were used to evaluate associations between IFU sizing and demographics. Logistic regression modeling was used to identify predictors of outside IFU sizing. Cox proportional hazards regression analyzed the relationship between sizing and endoleak, device-related reinterventions, and all-cause/aortic mortality. RESULTS: There were 3607 EVAR subjects enrolled in GREAT as of March 2020. Of them, 1896 (53%) were within IFU for sizing, 791 (22%) were oversized, 540 (15%) were undersized, and 380 (10%) had both over- and undersized components. Factors predictive of use outside of IFU included female sex (P = .001), non-white race (P = .0003), decreased proximal neck length (P < .061), or larger iliac diameters (P < .0001). Women were more likely than men to have proximal neck undersizing and iliac limb oversizing, and men were more likely to have iliac limb undersizing. On multivariate analysis, undersizing of the proximal graft was associated with endoleak (hazard ratio [HR], 1.8) and aortic (HR, 60.5) and all-cause (HR, 18.0) mortality. Undersizing of iliac limbs was associated with endoleak (HR, 1.5) and device-related reintervention (HR, 1.4). Iliac limb outside IFU sizing was associated with aortic (HR, 2.6) and all-cause (HR, 1.3) mortality. Proximal and distal oversizing was not associated with adverse outcomes. Female sex was associated with mortality on univariate but not multivariate analysis. CONCLUSIONS: Women undergoing EVAR with GORE EXCLUDER abdominal aortic aneurysm Endoprosthesis (W.L. Gore & Associates Inc, Flagstaff, Ariz) are more likely to have proximal stent-graft undersizing and iliac limb oversizing, whereas men are more likely to have undersized iliac limbs. Proximal aortic graft undersizing is associated with endoleak and all-cause/aortic mortality, whereas undersizing of iliac limbs is associated with endoleak and device-related reintervention. Oversizing was not associated with adverse outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Charlton-Ouw KM, Ikeno Y, Bokamper M, et al. Aortic endograft sizing and endoleak, reintervention, and mortality following endovascular aneurysm repair. J Vasc Surg. 2021. PMID: 33940075. doi:10.1016/j.jvs.2021.04.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。